Nirmatrelvir combined with ritonavir for preventing and treating COVID-19
{{output}}
Background: Oral nirmatrelvir/ritonavir (Paxlovid) aims to avoid severe COVID-19 in asymptomatic people or those with mild symptoms, thereby decreasing hospitalization and death. It remains to be evaluated for which indications a... ...
